Citadel Advisors’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
760,659
+417,006
| +121% | +$1.13M | ﹤0.01% | 2660 |
|
|
2025
Q1 | $773K | Buy |
343,653
+29,703
| +9% | +$66.8K | ﹤0.01% | 3560 |
|
|
2024
Q4 | $1.1M | Buy |
313,950
+183,692
| +141% | +$643K | ﹤0.01% | 3165 |
|
|
2024
Q3 | $535K | Sell |
130,258
-278,731
| -68% | -$1.15M | ﹤0.01% | 3724 |
|
|
2024
Q2 | $1.47M | Buy |
408,989
+365,082
| +831% | +$1.31M | ﹤0.01% | 2708 |
|
|
2024
Q1 | $145K | Sell |
43,907
-280,912
| -86% | -$927K | ﹤0.01% | 4932 |
|
|
2023
Q4 | $750K | Sell |
324,819
-1,917,606
| -86% | -$4.43M | ﹤0.01% | 3313 |
|
|
2023
Q3 | $2.89M | Buy |
2,242,425
+473,982
| +27% | +$611K | ﹤0.01% | 2060 |
|
|
2023
Q2 | $2.33M | Sell |
1,768,443
-1,279,517
| -42% | -$1.69M | ﹤0.01% | 2308 |
|
|
2023
Q1 | $2.15M | Sell |
3,047,960
-14,372
| -0.5% | -$10.2K | ﹤0.01% | 2471 |
|
|
2022
Q4 | $2.3M | Sell |
3,062,332
-13,555
| -0.4% | -$10.2K | ﹤0.01% | 2450 |
|
|
2022
Q3 | $2.65M | Buy |
3,075,887
+312,462
| +11% | +$269K | ﹤0.01% | 2471 |
|
|
2022
Q2 | $3.1M | Sell |
2,763,425
-1,142,910
| -29% | -$1.28M | ﹤0.01% | 2324 |
|
|
2022
Q1 | $4.38M | Sell |
3,906,335
-94,479
| -2% | -$106K | ﹤0.01% | 2204 |
|
|
2021
Q4 | $6.4M | Sell |
4,000,814
-73,806
| -2% | -$118K | ﹤0.01% | 1879 |
|
|
2021
Q3 | $9.86M | Buy |
4,074,620
+1,120,552
| +38% | +$2.71M | ﹤0.01% | 1457 |
|
|
2021
Q2 | $9.36M | Buy |
2,954,068
+516,810
| +21% | +$1.64M | ﹤0.01% | 1498 |
|
|
2021
Q1 | $8.21M | Sell |
2,437,258
-1,678,197
| -41% | -$5.66M | ﹤0.01% | 1595 |
|
|
2020
Q4 | $14.7M | Buy |
4,115,455
+4,097,346
| +22,626% | +$14.7M | ﹤0.01% | 1027 |
|
|
2020
Q3 | $47K | Buy |
+18,109
| New | +$47K | ﹤0.01% | 4404 |
|